<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01210248</url>
  </required_header>
  <id_info>
    <org_study_id>NO 51/10</org_study_id>
    <nct_id>NCT01210248</nct_id>
  </id_info>
  <brief_title>Correlation Between CYP2C19 Genotype, Level Of Clopidogrel Metabolite And Platelet Inhibition Status</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <brief_summary>
    <textblock>
      The aim of this study is to check correlation between CYP2C19 genotype level of clopidogrel
      metabolite in plasma and platelet inhibition status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      THE FIRST PHASE OF THE RESEARCH WILL INVOLVE PATIENTS RECRUITMENT AND INFORMED CONSENT FOR
      GENETIC TESTING.THE MAJORITY OF PATIENTS WILL BE RECRUITED FROM EMERGENCY DEPARTMENT. EVERY
      PATIENT WILL BE ASKED ABOUT HIS AND HIS PARENT'S ETHNICITY (ASHKENASI OR SEPHARDY JEW) AND
      ADDITIONAL DRUGS HE TAKES. IF PATIENT AGREES TO PARTICIPATE IN THE STUDY , HIS BLOOD SAMPLE
      WILL BE COLLECTED FOR 3 KINDS OF TESTS:

        1. GENETIC (FOR CYP450 2C19)

        2. PLATELET MAPPING TEST ( BY THROMBOELASTOGRAPH ASSAY)

        3. CLOPIDOGREL INACTIVE METABOLITE DETERMINATION BY CHROMATOGRAPHIC METHOD
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <primary_completion_date>January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">500</enrollment>
  <condition>PRIMARY FOCUS:PATIENT THAT TAKE CLOPIDOGREL</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BLOOD COLLECTION</intervention_name>
    <description>BLOOD SAMPLE WILL BE COLLECTED FOR 3 KINDS OF TESTS</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        THE RESEARCH WILL INVOLVE PATIENTS THAT TAKE CLOPIDOGREL AND READY TO GIVE INFORMED CONSENT
        FOR GENETIC TESTING.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 OLD PATIENTS

          -  THAT TAKE CLOPIDOGREL MORE THAN 1 WEEK

        Exclusion Criteria:

          -  PREGNANCY

          -  CHRONIC LIVER DISEASES
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>ADINA BAR HAIM, PhD</last_name>
    <phone>08-9779897</phone>
    <email>dinab@asaf.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>VICTORIA PAPIASHVILI, M.Sc</last_name>
    <phone>0577345973</phone>
    <email>victoriapapi@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Zeriffin</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ADINA BAR HAIM, PhD</last_name>
      <phone>08-9779897</phone>
      <email>dinab@asaf.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>VICTORIA PAPIASHVILI, M.Sc</last_name>
      <email>victoriapapi@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2010</study_first_submitted>
  <study_first_submitted_qc>September 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2010</study_first_posted>
  <last_update_submitted>September 27, 2010</last_update_submitted>
  <last_update_submitted_qc>September 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2010</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

